BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Therapix Biosciences Initiates Non-clinical Studies for its Antibacterial Program in Collaboration With the Weizmann Institute of Science and Tel Aviv Sourasky Medical Center

  Therapix has initiated non-clinical studies to evaluate the efficacy of its proprietary compound THX-150, a pharma composition of dronabinol in collaboration with the Weizmann Institute of Science and the Tel Aviv Sourasky Medical Center.

  October 30, 2017

   · 

  7 min read
• Business

  Antares Vision North America and Xyntek Renew Strategic Partnership for U.S. Sales of Serialization Aggregation Solutions

  Antares Vision has renewed its strategic partnership with Xyntek which means that Xyntek will continue to sell and service solutions in the Antares Track System platform throughout the U.S.

  October 30, 2017

   · 

  3 min read
• Business

  Endo Announces Certain Preliminary Financial Results for Third-Quarter 2017 and Affirms Selected 2017 Financial Guidance

  Endo International today announced certain preliminary results for the quarter ended September 30, 2017 and also affirmed that for the twelve months ending December 31, 2017, the Company expects revenues to be between $3.38B and $3.53B.

  October 30, 2017

   · 

  15 min read
• Deals

  BERG Enters Into an Agreement With Sanofi Pasteur to Identify Biomarkers of Flu Vaccine Performance

  BERG today announced a new research effort with Sanofi Pasteur, the influenza vaccine global leader.

  October 30, 2017

   · 

  3 min read
• Business

  Boehringer Ingelheim Expands Collaboration With Sarah Cannon Research Institute to Investigate Novel Immuno-Oncology Combination Therapy

  Boehringer Ingelheim and Sarah Cannon Research Institute today announced an expansion of their strategic partnership which combines Boehringer Ingelheim’s oncology research and Sarah Cannon’s expertise in clinical trial design.

  October 30, 2017

   · 

  5 min read
• 

  FDA

  NeoLight Wins FDA Nod for Medical Device Poised to Disrupt Newborn Care Market

  Through its empathy-driven innovation model, NeoLight develops technologies that treat infants with life threatening medical conditions.

  October 30, 2017

   · 

  1 min read
• Bio NC

  CMP Pharma Announces That CaroSpir, the First and Only FDA-Approved Spironolactone Oral Suspension, is Now Available

  CaroSpir was approved by the FDA on August 4, 2017 and is now available through normal retail distribution.

  October 30, 2017

   · 

  4 min read
• Deals

  Arthrosurface Acquires an Acellular Dermal Technology From WASAS, LLC

  ArthroSurface announced today that it has completed the acquisition of an acellular dermal stabilization device technology, including the intellectual property rights to and associated with this technology, from WASAS, LLC.

  October 30, 2017

   · 

  1 min read
• Policy

  NewLink Genetics Announces FDA Orphan-Drug Designation for Indoximod

  Indoximod is aimed at treating patients with Stage IIb-IV melanoma.

  October 30, 2017

   · 

  3 min read
• Drug Development

  Mateon Therapeutics Announces Updated Data from Fifth Cohort of Phase Ib Study of OXi4503 in Acute Myeloid Leukemia

  Mateon previously reported that two of four patients in this cohort of the study had morphological complete remissions following one cycle of treatment with OXi4503.

  October 30, 2017

   · 

  5 min read